XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Previously Reported
Adjustment
Common Stock
Common Stock
Previously Reported
Common Stock
Revision of Prior Period, Adjustment
Additional Paid-in Capital
Additional Paid-in Capital
Previously Reported
Additional Paid-in Capital
Revision of Prior Period, Adjustment
Accumulated Deficit
Accumulated Deficit
Previously Reported
Accumulated Deficit
Adjustment
Beginning Balance (in shares) at Dec. 31, 2021       65,772,001 45,176,145 20,595,856            
Beginning Balance at Dec. 31, 2021 $ 13,858 $ 13,858 $ (154) $ 7 $ 1 $ 6 $ 89,252 $ 89,258 $ (6) $ (75,401) $ (75,401) $ (154)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Exercise of stock options (in shares)       4,549                
Exercise of stock options 8           8          
Capital contributions from Amprius Holdings 247           247          
Stock-based compensation 350           350          
Contribution from Amprius Holdings related to stock-based compensation 106           106          
Net loss (2,878)                 (2,878)    
Ending Balance (in shares) at Mar. 31, 2022       65,776,550                
Ending Balance at Mar. 31, 2022 $ 11,537     $ 7     89,963     (78,433)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-02 [Member]                      
Beginning Balance (in shares) at Dec. 31, 2022 84,610,114     84,610,114                
Beginning Balance at Dec. 31, 2022 $ 73,033     $ 8     165,912     (92,887)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of common stock in connection with a stock purchase agreement, net of issuance cost (in shares)       331,351                
Issuance of common stock in connection with a stock purchase agreement, net of issuance cost 2,376           2,376          
Exercise of stock options (in shares)       30,000                
Exercise of stock options 2           2          
Stock-based compensation 723           723          
Contribution from Amprius Holdings related to stock-based compensation 3           3          
Net loss $ (9,102)                 (9,102)    
Ending Balance (in shares) at Mar. 31, 2023 84,610,114     84,971,465                
Ending Balance at Mar. 31, 2023 $ 67,035     $ 8     $ 169,016     $ (101,989)